These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 15919175

  • 21. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
    Pendyala L, Kidani Y, Perez R, Wilkes J, Bernacki RJ, Creaven PJ.
    Cancer Lett; 1995 Nov 06; 97(2):177-84. PubMed ID: 7497460
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C.
    J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897
    [Abstract] [Full Text] [Related]

  • 27. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK, Husain I, Sancar A, Chaney SG.
    Cancer Res; 1986 Jun 20; 46(6):2876-82. PubMed ID: 3698013
    [Abstract] [Full Text] [Related]

  • 28. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 20; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 29. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
    Kizu R, Nakanishi T, Hayakawa K, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Tashiro T, Kidani Y.
    Cancer Chemother Pharmacol; 1999 Dec 20; 43(2):97-105. PubMed ID: 9923814
    [Abstract] [Full Text] [Related]

  • 30. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.
    Anticancer Res; 1996 Dec 20; 16(1):33-8. PubMed ID: 8615631
    [Abstract] [Full Text] [Related]

  • 31. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R, Khokhar AR, Claringbold P, Kasi LP, Lopez-Berestein G.
    J Natl Cancer Inst; 1986 Nov 20; 77(5):1137-43. PubMed ID: 2430132
    [Abstract] [Full Text] [Related]

  • 32. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
    Kizu R, Nakanishi T, Miyazaki M, Tashiro T, Noji M, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Kidani Y.
    Anticancer Drugs; 1996 May 20; 7(3):248-56. PubMed ID: 8791997
    [Abstract] [Full Text] [Related]

  • 33. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
    Anderson WK, Quagliato DA, Haugwitz RD, Narayanan VL, Wolpert-DeFilippes MK.
    Cancer Treat Rep; 1986 Aug 20; 70(8):997-1002. PubMed ID: 3731155
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
    Zhang J, Li Y, Sun J.
    Eur J Med Chem; 2009 Jun 20; 44(6):2758-62. PubMed ID: 19056150
    [Abstract] [Full Text] [Related]

  • 35. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L, Di Mario F, Botti P, Ragazzi E, Martelli M, Kelland L.
    Biochem Pharmacol; 2007 Jun 30; 74(1):20-7. PubMed ID: 17466278
    [Abstract] [Full Text] [Related]

  • 36. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M, Balázová E, Kiss F, Kovácová J, Ujházy V.
    Neoplasma; 1989 Jun 30; 36(6):651-7. PubMed ID: 2615869
    [Abstract] [Full Text] [Related]

  • 37. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].
    Shamsuddin S, Santillan CC, Stark JL, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 1998 Aug 30; 71(1-2):29-35. PubMed ID: 9755489
    [Abstract] [Full Text] [Related]

  • 38. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V, Grossi L, Munari D, Pollicino S, Martelli L, Martelli M.
    Anticancer Res; 2006 Aug 30; 26(3A):1815-9. PubMed ID: 16827112
    [Abstract] [Full Text] [Related]

  • 39. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R, Khokhar AR, Lopez-Berestein G.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L, Zivkovic MD, Veselinovic A, Pavic A, Djuran MI, Rajkovic S, Nikodinovic-Runic J.
    J Med Chem; 2015 Feb 12; 58(3):1442-51. PubMed ID: 25551180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.